Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
145.7 USD | -0.23% |
|
-0.77% | -7.05% |
07-03 | Johnson & Johnson's Rybrevant Approved by Health Canada to Treat Advanced Lung Cancer | MT |
07-03 | Johnson & Johnson Lung Cancer Drug Gets Health Canada Approval | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
1st Jan change | Capi. | |
---|---|---|
-7.05% | 351B | |
+54.07% | 809B | |
+39.38% | 621B | |
+15.44% | 319B | |
+5.72% | 289B | |
+14.62% | 238B | |
-0.41% | 221B | |
+14.54% | 218B | |
+7.42% | 166B | |
-3.79% | 157B |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- Johnson & Johnson Says Interim Analysis of Blood Cancer Therapy Study Show Promise